Vascular Calcification: Clinical Trials

9 trials for Vascular Calcification, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed. 9 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 39Completed 9
Phase 21Completed 1

Follow Vascular Calcification: new trials by email Literature Review of Vascular Calcification trials Research Report on Vascular Calcification

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SGLT2 Inhibitors in Non-Diabetic CKD: Effects on Vascular Calcification and Anemia
Dapagliflozin (10Mg Tab) along with standard medical therapy, Placebo - Chronic Kidney Disease, Anemia
Phase 3CompletedMansoura University1002022-09-012026-01-15
Cholecalciferol on Hemodialysis Patients
Cholecalciferol, Placebo - Hemodialysis Complication, Vitamin D Deficiency
Phase 2 / Phase 3CompletedAin Shams University602018-07-012019-01-09
Prevention of the Progression of Coronary Calcification With Use of Spironolactone in Peritoneal Dialysis Patients
Spironolactone 25Mg Tablet - Coronary Artery Calcification, Vascular Calcification
Phase 3CompletedProfessor Fernando Figueira Integral Medicine Institute332014-11-072017-10-19
Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate in Hemodialysis Patients : Landmark Study
Lanthanum Carbonate, Calcium Carbonate - Hemodialysis, Hyperphosphatemia
Phase 3CompletedTranslational Research Center for Medical Innovation, Kobe, Hyogo, Japan23092011-12-242020-11-30
Dose Defining Study for the Administration of Vitamin K2 Supplements in Hemodialysis Patients
Vitamin K2 supplementation - Vascular Calcification
Phase 3CompletedRogier Caluwe1652011-05-012012-08-29
Queen's University Investigation of Calcification in Chronic Kidney Disease
Bisphosphonate, Placebo - Chronic Kidney Disease
Phase 3CompletedQueen's University252008-10-012015-09-28
Vitamin K2 Supplementation to Activate Matrix Gla Protein (MGP) as Endogenous Inhibitor of Vascular Calcification in Hemodialysis Patients
daily supplementation of MK-7 over 6 weeks - CKD 5D, Hemodialysis
Phase 3CompletedRWTH Aachen University532008-01-012011-08-02
Atorvastatin Treatment to Attenuate the Progression of Cardiovascular Disease in Hemodialysis Patients
atorvastatin, placebo - Vascular Calcification, Atherosclerosis
Phase 3CompletedErcan OK4462006-11-012013-09-09
Effect of Vitamin K on Age-Related Bone Loss and Vascular Calcification
Vitamin K - Osteoporosis, Vascular Calcification
Phase 3CompletedNational Institute on Aging (NIA)4522001-10-012009-02-16

Narrower conditions

Inflammation (2)  ·  Renal Insufficiency, Chronic (2)  ·  Anemia (1)  ·  Atherosclerosis (1)  ·  Chronic Kidney Disease-Mineral and Bone Disorder (1)  ·  Dyslipidemias (1)  ·  Hyperphosphatemia (1)  ·  Kidney Failure, Chronic (1)  ·  Osteoporosis (1)  ·  Vitamin D Deficiency (1)  ·  Vitamin K Deficiency (1)

Broader conditions

Calcinosis (9)  ·  Calcium Metabolism Disorders (9)  ·  Metabolic Diseases (9)  ·  Nutritional and Metabolic Diseases (9)  ·  Pathologic Processes (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Avitaminosis (3)  ·  Chronic Disease (3)  ·  Deficiency Diseases (3)  ·  Disease Attributes (3)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Kidney Diseases (3)  ·  Male Urogenital Diseases (3)  ·  Malnutrition (3)

Interventions

Tablets (2)  ·  Atorvastatin (1)  ·  Calcium Carbonate (1)  ·  Cholecalciferol (1)  ·  Diphosphonates (1)  ·  Spironolactone (1)  ·  Vitamin K (1)  ·  dapagliflozin (1)  ·  lanthanum carbonate (1)

Sponsors

Ain Shams University (1)  ·  Ercan OK (1)  ·  Mansoura University (1)  ·  National Institute on Aging (NIA) (1)  ·  Professor Fernando Figueira Integral Medicine Institute (1)  ·  Queen's University (1)  ·  RWTH Aachen University (1)  ·  Rogier Caluwe (1)  ·  Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan (1)

Countries

Egypt (2)  ·  Brazil (1)  ·  Canada (1)  ·  Germany (1)  ·  Japan (1)  ·  Turkey (Türkiye) (1)  ·  United States (1)

Top investigators

Alex SR Souza, PhD (1)  ·  Aluizio B Carvalho, PhD (1)  ·  An Devriese, MD, PhD (1)  ·  Ana Paula S Gueiros, MD (1)  ·  Bruno Van Vlem, MD, PhD (1)  ·  Dulce E Casarini, PhD (1)  ·  Ercan Ok, MD (1)  ·  Eveline B Calado, MD (1)  ·  Georg Schlieper, MD (1)  ·  Juergen Floege, MD (1)  ·  Karen E Yeates, Dr (1)  ·  Karina T Nobrega, MD (1)  ·  Leuridan T Cavalcante, PhD (1)  ·  Marina M Cadena (1)

Results publications

PMID 12935835, PMID 16973975, PMID 18625626, PMID 18689371, PMID 18697901, PMID 19386744, PMID 19776145, PMID 20237066, PMID 20719580, PMID 21628633, PMID 22169620, PMID 22955514, PMID 23719555, PMID 24184249, PMID 33586138, PMID 33594986, PMID 34003226, PMID 40576086

NIH funding

R01AG019147 (1), R01HL069272 (1)